Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
Status: Enrolling
Updated:  9/29/2015
The Mayo Clinic
mi
from
Rochester, MN
A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
Status: Enrolling
Updated: 9/29/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
mi
from
Madison, WI
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated:  10/7/2015
Cancer Care of Western North Carolina
mi
from
Asheville, NC
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated: 10/7/2015
Cancer Care of Western North Carolina
mi
from
Asheville, NC
Click here to add this to my saved trials
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated:  10/7/2015
Moses Cone Regional Cancer Center at Wesley Long Community Hospital
mi
from
Greensboro, NC
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated: 10/7/2015
Moses Cone Regional Cancer Center at Wesley Long Community Hospital
mi
from
Greensboro, NC
Click here to add this to my saved trials
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated:  10/7/2015
Leo W. Jenkins Cancer Center at ECU Medical School
mi
from
Greenville, NC
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated: 10/7/2015
Leo W. Jenkins Cancer Center at ECU Medical School
mi
from
Greenville, NC
Click here to add this to my saved trials
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated:  10/7/2015
Rex Cancer Center at Rex Hospital
mi
from
Raleigh, NC
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated: 10/7/2015
Rex Cancer Center at Rex Hospital
mi
from
Raleigh, NC
Click here to add this to my saved trials
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated:  10/7/2015
Marion L. Shepard Cancer Center
mi
from
Washington, NC
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
Multicenter Study Investigating Utilization of Pharmacokinetic-Guided 5-Fluorouracil in Patients Receiving mFOLFOX6 With or Without Bevacizumab
Status: Enrolling
Updated: 10/7/2015
Marion L. Shepard Cancer Center
mi
from
Washington, NC
Click here to add this to my saved trials
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
Effect of Daikenchuto (TU 100), a Gastrointestinal Nerve Modulator, on Rectal Sensation in Patients With Irritable Bowel Syndrome
Status: Enrolling
Updated:  10/14/2015
Mayo Clinic, Rochester Methodist CRU
mi
from
Rochester, MN
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
Effect of Daikenchuto (TU 100), a Gastrointestinal Nerve Modulator, on Rectal Sensation in Patients With Irritable Bowel Syndrome
Status: Enrolling
Updated: 10/14/2015
Mayo Clinic, Rochester Methodist CRU
mi
from
Rochester, MN
Click here to add this to my saved trials
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences
Status: Enrolling
Updated:  11/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences
Status: Enrolling
Updated: 11/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease
NIH SUBSTUDY:Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of Two Single Infusions of AIN457 in Patients With Moderate to Severe Active Crohn's Disease
Status: Enrolling
Updated:  12/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease
NIH SUBSTUDY:Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of Two Single Infusions of AIN457 in Patients With Moderate to Severe Active Crohn's Disease
Status: Enrolling
Updated: 12/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Effect of Lactobacillus Acidophilus CL1285 and Lactobacillus Casei LBC80R on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Status: Enrolling
Updated:  12/11/2015
Digestive and Liver Disease Specialists A Medical Group. Inc
mi
from
Garden Grove, CA
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Effect of Lactobacillus Acidophilus CL1285 and Lactobacillus Casei LBC80R on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Status: Enrolling
Updated: 12/11/2015
Digestive and Liver Disease Specialists A Medical Group. Inc
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Effect of Lactobacillus Acidophilus CL1285 and Lactobacillus Casei LBC80R on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Status: Enrolling
Updated:  12/11/2015
Sprim ALS
mi
from
San Francisco, CA
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Effect of Lactobacillus Acidophilus CL1285 and Lactobacillus Casei LBC80R on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Status: Enrolling
Updated: 12/11/2015
Sprim ALS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Effect of Lactobacillus Acidophilus CL1285 and Lactobacillus Casei LBC80R on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Status: Enrolling
Updated:  12/11/2015
Westlake Medical Research
mi
from
Westlake Village, CA
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Effect of Lactobacillus Acidophilus CL1285 and Lactobacillus Casei LBC80R on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Status: Enrolling
Updated: 12/11/2015
Westlake Medical Research
mi
from
Westlake Village, CA
Click here to add this to my saved trials
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
An Open-label, Pilot Study to Compare the Safety and Immunogenicity of an Alternate Dosing Schedule (2-5 Weeks, 2 Months, and 4 Months) for Pentavalent Rotavirus Vaccine (RotaTeq) to the Standard Recommended Schedule (2, 4, and 6 Months)
Status: Enrolling
Updated:  1/7/2016
Duke University Health System
mi
from
Durham, NC
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
An Open-label, Pilot Study to Compare the Safety and Immunogenicity of an Alternate Dosing Schedule (2-5 Weeks, 2 Months, and 4 Months) for Pentavalent Rotavirus Vaccine (RotaTeq) to the Standard Recommended Schedule (2, 4, and 6 Months)
Status: Enrolling
Updated: 1/7/2016
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI)
A Randomized Open Label Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI)
Status: Enrolling
Updated:  1/11/2016
21st Century Oncology
mi
from
Jacksonville, FL
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI)
A Randomized Open Label Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI)
Status: Enrolling
Updated: 1/11/2016
21st Century Oncology
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls
Status: Enrolling
Updated:  1/12/2016
Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls
Status: Enrolling
Updated: 1/12/2016
Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
University of Michigan
mi
from
Ann Arbor, MI
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
MD2Me - Texting to Promote Chronic Disease Management
TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Status: Enrolling
Updated:  1/25/2016
The University of California, San Diego
mi
from
La Jolla, CA
MD2Me - Texting to Promote Chronic Disease Management
TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Status: Enrolling
Updated: 1/25/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease
Status: Enrolling
Updated:  1/26/2016
Children's Hospital
mi
from
Boston, MA
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease
Status: Enrolling
Updated: 1/26/2016
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated:  1/26/2016
Boston Clinical Site
mi
from
Boston, MA
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated: 1/26/2016
Boston Clinical Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated:  1/26/2016
Chapel Hill Clinical Site
mi
from
Chapel Hill, NC
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated: 1/26/2016
Chapel Hill Clinical Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated:  1/26/2016
Oklahoma City Clinical Site
mi
from
Oklahoma, OK
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated: 1/26/2016
Oklahoma City Clinical Site
mi
from
Oklahoma, OK
Click here to add this to my saved trials
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated:  1/26/2016
St. Louis Clinical Site
mi
from
St. Louis, MO
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
Status: Enrolling
Updated: 1/26/2016
St. Louis Clinical Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
Ability of Mayo Clinic HPLC Method to Measure Fecal Bile Acids to Demonstrate Response to Colesevelam in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated:  1/26/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
Ability of Mayo Clinic HPLC Method to Measure Fecal Bile Acids to Demonstrate Response to Colesevelam in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 1/26/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Status: Enrolling
Updated:  2/10/2016
UCLA Pediatric Pain Management Clinic
mi
from
Los Angeles, CA
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Status: Enrolling
Updated: 2/10/2016
UCLA Pediatric Pain Management Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  2/16/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 2/16/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Recurrent Abdominal Pain in Children
Recurrent Abdominal Pain in Children
Status: Enrolling
Updated:  3/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Recurrent Abdominal Pain in Children
Recurrent Abdominal Pain in Children
Status: Enrolling
Updated: 3/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Probiotics in Adults With Irritable Bowel Syndrome
Phase I, Open Label Safety Study of VSL#3 in Adults With Irritable Bowel Syndrome
Status: Enrolling
Updated:  3/4/2016
Baylor Clinic
mi
from
Houston, TX
Safety Study of Probiotics in Adults With Irritable Bowel Syndrome
Phase I, Open Label Safety Study of VSL#3 in Adults With Irritable Bowel Syndrome
Status: Enrolling
Updated: 3/4/2016
Baylor Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Probiotics in Adults With Irritable Bowel Syndrome
Phase I, Open Label Safety Study of VSL#3 in Adults With Irritable Bowel Syndrome
Status: Enrolling
Updated:  3/4/2016
Univerisity of Washington
mi
from
Seattle, WA
Safety Study of Probiotics in Adults With Irritable Bowel Syndrome
Phase I, Open Label Safety Study of VSL#3 in Adults With Irritable Bowel Syndrome
Status: Enrolling
Updated: 3/4/2016
Univerisity of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated:  3/9/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated: 3/9/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome
Status: Enrolling
Updated:  3/10/2016
University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology
mi
from
Chapel Hill, NC
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome
Status: Enrolling
Updated: 3/10/2016
University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Anniston Clinical Site
mi
from
Anniston, AL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Anniston Clinical Site
mi
from
Anniston, AL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Goodyear Clinical Site
mi
from
Goodyear, AZ
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Goodyear Clinical Site
mi
from
Goodyear, AZ
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Tucson Clinical Site 133
mi
from
Tucson, AZ
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Tucson Clinical Site 133
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
North Little Rock Clinical Site
mi
from
North Little Rock, AR
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
North Little Rock Clinical Site
mi
from
North Little Rock, AR
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Carlsbad Clinical Site
mi
from
Carlsbad, CA
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Carlsbad Clinical Site
mi
from
Carlsbad, CA
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
San Diego Clinical Site 140
mi
from
San Diego, CA
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
San Diego Clinical Site 140
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Boynton Beach Clinical Site
mi
from
Boynton Beach, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Boynton Beach Clinical Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Clearwater Clinical Site
mi
from
Clearwater, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Clearwater Clinical Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Deland Clinical Site
mi
from
Deland, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Deland Clinical Site
mi
from
Deland, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Hialeah Clinical Site
mi
from
Hialeah, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Hialeah Clinical Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Lauderdale Lakes Clinical Site
mi
from
Lauderdale Lakes, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Lauderdale Lakes Clinical Site
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Orlando Clinical Site
mi
from
Orlando, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Orlando Clinical Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Port Orange Clinical Site
mi
from
Port Orange, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Port Orange Clinical Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
South Miami Clinical Site
mi
from
South Miami, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
South Miami Clinical Site
mi
from
South Miami, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
St. Petersburg Clinical Site
mi
from
St. Petersburg, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
St. Petersburg Clinical Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
Tampa Clinical Site
mi
from
Tampa, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
Tampa Clinical Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  3/17/2016
West Palm Clinical Site
mi
from
West Palm, FL
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 3/17/2016
West Palm Clinical Site
mi
from
West Palm, FL
Click here to add this to my saved trials